During the past decade, Peter J. Ruane, MD, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 23 clinical trials were completed, i.e. on average, 255.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peter J. Ruane, MD, Inc." #1 sponsor was "Gilead Sciences" with 28 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Galena Biopharma, Inc." with 2 trials sponsored, "Peter J. Ruane, M.D., Inc." with 2 trials sponsored and "Peter J. Ruane, M.D." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peter J. Ruane, MD, Inc." #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Janssen Scientific Affairs, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Peter J. Ruane, MD, Inc." are "HIV Infections" (17 trials), "Acquired Immunodeficiency Syndrome" (8 trials), "HIV" (8 trials), "HIV-1 Infection" (6 trials) and "Chronic Hepatitis C" (5 trials). Many other conditions were trialed in "Peter J. Ruane, MD, Inc." in a lesser frequency.

Most popular intervention types in "Peter J. Ruane, MD, Inc." are "Drug" (37 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (8 trials), "FTC/TDF" (7 trials), "COBI" (6 trials), "Stribild" (6 trials) and "ATV" (5 trials). Other intervention names were less common.

The vast majority of trials in "Peter J. Ruane, MD, Inc." are 37 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Peter J. Ruane, MD, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Peter J. Ruane, MD, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peter J. Ruane, MD, Inc., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".